* The beneficial ownership for which figures are provided in this column is the shared, not sole, power to vote or to direct the vote of the Shares, and the shared, not sole, power to dispose or to direct the disposition of the Shares. To account for rounding differences in prior conversion calculations for derivative securities, the beneficial ownership of each of the Blue Line Fund, HCP II and HCP II GP has been increased by approximately 10 Shares, the beneficial ownership of the Master Fund, Harbinger LLC, and Harbinger Holdings has been increased by less than one Share, and the beneficial ownership of Mr. Falcone has been increased by approximately 11 Shares.
** Each figure is based on 139,466,034 Shares outstanding (as of August 2, 2010, according to the Issuer’s most recent Form 10-Q, filed on August 6, 2010), adjusted for derivative securities held by the Reporting Person.
(c) The trading dates, number of Shares and derivative securities acquired and disposed of, and the price per Share and derivative security for the transactions by the Reporting Persons, in the past sixty days, separate from the transactions reported on the prior Schedule 13D, are set forth in the schedule of transactions attached hereto as Exhibit B. The transactions were effected in the open market through a broker.
(d) This Item 5(d) is not applicable.
(e) This Item 5(e) is not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
This Item 6 is not applicable.
Item 7. Material to be Filed as Exhibits
Exhibit A: Joint Filing Agreement
Exhibit B: Schedule of Transactions